Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(4)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06888128Phase 2Recruiting

State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma

Role: collaborator

NCT07220057Not ApplicableCompleted

Sustainable Culturally Adapted Nutrition (SCAN) Program

Role: collaborator

NCT03021928Phase 3Unknown

Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

Role: collaborator

NCT04625998Not ApplicableCompleted

Texas Childhood Obesity Research Demonstration (TX CORD) Project -Primary Prevention Study

Role: collaborator

NCT02724943Not ApplicableCompleted

Texas Childhood Obesity Research Demonstration (TX CORD) Project

Role: collaborator

NCT02128776Not ApplicableCompleted

An Enhanced Medical Home for High-Risk Chronically Ill Children

Role: collaborator

All 6 trials loaded